Paragon Genomics and Genecast Announce Global Partnership to Advance Precision Oncology
Leaders in pioneering cancer diagnostics and NGS target enrichment technologies join forces to accelerate access to advanced molecular diagnostics for...
Cancer
Corbus Pharmaceuticals Announces Upcoming Presentation of Dose Expansion Phase 1/2 Clinical Data for its Nectin-4 Targeting ADC CRB-701 at the 2025 ESMO Annual Congress
NORWOOD, Mass., July 30, 2025 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings Inc. (NASDAQ: CRBP), a clinical-stage company focused on oncology...
BriaCell Awarded New Zealand Patent for its Whole Cell Technology
PHILADELPHIA and VANCOUVER, British Columbia, July 30, 2025 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW, BCTXZ) (TSX: BCT)...
Sensei Biotherapeutics to Present Clinical Data from the Phase 1 Dose Expansion Cohort of Solnerstotug at the ESMO Congress 2025
BOSTON, July 30, 2025 (GLOBE NEWSWIRE) -- Sensei Biotherapeutics, Inc. (NASDAQ: SNSE), a clinical stage immuno-oncology company focused on the...
Pancreatic Cancer Phase 2a Study with Can-Fite’s Namodenoson Achieved Over 50% Enrollment Milestone
Primary endpoint is safety; Namodenoson continues to demonstrate a favorable safety profile Ramat Gan, Israel, July 30, 2025 (GLOBE NEWSWIRE)...
COTA partners with LCP Health Analytics to advance the use of US RWD to support HTA decision making internationally
US + UK Data to Address Key Evidence Gaps in Access to Medicines NEW YORK, July 30, 2025 /PRNewswire/ --...
TriSalus Life Sciences to Host Second Quarter 2025 Financial Results Conference Call
Conference Call and Webcast Scheduled for Tuesday August 12, 2025 at 4:30 PMWESTMINSTER, Colo.--(BUSINESS WIRE)--TriSalus Life Sciences, Inc. (Nasdaq: TLSI)...
Rapid Expansion and Innovation Drive $36 Billion Global Point-of-Care Diagnostics Market, Says New Kalorama Report
ARLINGTON, Va., July 29, 2025 /PRNewswire/ -- A new report from Kalorama Information reveals that the global point-of-care (POC) diagnostics market...
In the Age of Automation, Human Collaboration Still Counts: Survey Highlights Critical Role of Medical Lab Staff, Influences on Doctors’ Orders
Empowered patients, inadequate healthcare coverage, and systemic pressure are factors influencing doctors’ test orders and intensifying doctors’ collaboration with dwindling...
In the Age of Automation, Human Collaboration Still Counts: Survey Highlights Critical Role of Medical Lab Staff, Influences on Doctors’ Orders
Empowered patients, inadequate healthcare coverage, and systemic pressure are factors influencing doctors’ test orders and intensifying doctors’ collaboration with dwindling...
Body Vision Medical Receives Regulatory Approval for LungVision® in Brazil, Expanding Access to AI-Driven Advanced Imaging for Lung Cancer Diagnosis
WALTHAM, Mass., July 29, 2025 /PRNewswire/ -- Body Vision Medical, a global leader in AI-powered intraoperative imaging, is proud to...
AIM ImmunoTech Announces Pricing of $8.0 Million Public Offering
OCALA, Fla., July 29, 2025 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (the “Company”), today announced the pricing...
The International Myeloma Foundation Mourns the Loss of Accomplished Attorney and Longtime Board Member Benson Klein
STUDIO CITY, Calif., July 29, 2025 (GLOBE NEWSWIRE) -- Today, the International Myeloma Foundation (IMF) announces with great sadness the...
Achieve Life Sciences to Participate in the BTIG Virtual Biotechnology Conference
SEATTLE and VANCOUVER, British Columbia, July 29, 2025 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage specialty...
IMUNON to Hold Second Quarter 2025 Financial Results and Business Update Conference Call on Tuesday, August 5, 2025
LAWRENCEVILLE, N.J., July 29, 2025 (GLOBE NEWSWIRE) -- IMUNON, Inc. (NASDAQ: IMNN), a clinical-stage company in late-stage development with its...
ProPhase Labs Announces Special Meeting of Shareholders and Filing of Preliminary Proxy Statement
Proxy Sets Company on a Path to Attract the Optimal Crypto Treasury Strategy Increase in Authorized Shares to 1 Billion...
Immutep to Present Pivotal TACTI-004 Trial in Progress Poster at the 2025 World Conference on Lung Cancer
SYDNEY, AUSTRALIA, July 29, 2025 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep” or “the Company”), a late-stage...
UroGen Pharma to Report Second Quarter 2025 Financial Results on Thursday, August 7th, 2025
Conference Call and Webcast Scheduled for Thursday, August 7th, 2025, at 10:00 AM ET PRINCETON, N.J., July 29, 2025 (GLOBE...
Calidi Biotherapeutics Receives FDA Fast Track Designation for CLD-201 (SuperNova), a First-In-Class Stem-Cell Loaded Viral Therapy for the Treatment of Patients with Soft Tissue Sarcoma
SAN DIEGO, July 29, 2025 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics, Inc. (“Calidi” or the “Company”) (NYSE American: CLDI), a clinical-stage...
Izotropic’s IzoView Breast CT Device Stands Distinct vs Existing Breast Imaging Technologies
- IzoView positioned to disrupt high-growth breast imaging markets with target device price of USD $500K - IzoView to launch...